S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
Log in

NYSE:MEDMedifast Stock Price, Forecast & News

$68.80
+1.85 (+2.76 %)
(As of 04/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$68.31
Now: $68.80
$70.26
50-Day Range
$51.98
MA: $73.50
$103.68
52-Week Range
$49.03
Now: $68.80
$159.41
Volume261,703 shs
Average Volume309,103 shs
Market Capitalization$809.43 million
P/E Ratio10.70
Dividend Yield6.75%
Beta1.07
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, franchise weight loss clinics, and direct consumer marketing. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
Read More
Medifast logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.18 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products
SectorConsumer Staples
CUSIP58470H10
Phone410-581-8042

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$713.67 million
Cash Flow$7.27 per share
Book Value$9.03 per share

Profitability

Net Income$77.92 million

Miscellaneous

Employees420
Market Cap$809.43 million
Next Earnings Date5/6/2020 (Estimated)
OptionableOptionable

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.


Medifast (NYSE:MED) Frequently Asked Questions

How has Medifast's stock been impacted by COVID-19 (Coronavirus)?

Medifast's stock was trading at $70.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MED shares have decreased by 2.3% and is now trading at $68.80. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Medifast?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Medifast.

When is Medifast's next earnings date?

Medifast is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for Medifast.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) released its quarterly earnings data on Wednesday, February, 26th. The specialty retailer reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.59. The specialty retailer had revenue of $170.63 million for the quarter, compared to analysts' expectations of $162 million. Medifast had a return on equity of 62.24% and a net margin of 10.92%. View Medifast's earnings history.

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Thursday, March 19th. Shareholders of record on Tuesday, March 31st will be given a dividend of $1.13 per share on Wednesday, May 6th. This represents a $4.52 dividend on an annualized basis and a dividend yield of 6.57%. The ex-dividend date is Monday, March 30th. View Medifast's dividend history.

What guidance has Medifast issued on next quarter's earnings?

Medifast updated its FY20 earnings guidance on Wednesday, February, 26th. The company provided earnings per share guidance of $6.25 to $6.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.84. The company issued revenue guidance of $715.0 million to $745.0 million, compared to the consensus revenue estimate of $798.90 million.

What price target have analysts set for MED?

3 analysts have issued 1 year price targets for Medifast's shares. Their forecasts range from $83.00 to $90.00. On average, they expect Medifast's stock price to reach $86.50 in the next twelve months. This suggests a possible upside of 25.7% from the stock's current price. View analysts' price targets for Medifast.

Has Medifast been receiving favorable news coverage?

News coverage about MED stock has trended very negative recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medifast earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news stories about the specialty retailer a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutMedifast.

Are investors shorting Medifast?

Medifast saw a drop in short interest during the month of March. As of March 13th, there was short interest totaling 3,583,600 shares, a drop of 5.7% from the February 27th total of 3,800,000 shares. Based on an average daily trading volume, of 299,100 shares, the short-interest ratio is presently 12.0 days. Approximately 31.9% of the shares of the stock are sold short. View Medifast's Current Options Chain.

Who are some of Medifast's key competitors?

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Home Depot (HD), Mastercard (MA), Paypal (PYPL), AbbVie (ABBV), Baidu (BIDU), Boeing (BA) and Adobe (ADBE).

Who are Medifast's key executives?

Medifast's management team includes the following people:
  • Mr. Daniel R. Chard, CEO & Director (Age 54)
  • Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 57)
  • Mr. William Baker IV, Exec. VP of Information Technology (Age 47)
  • Mr. Nicholas Johnson, Exec. VP of Coach Success Market Pres of OPTAVIA USA (Age 39)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 48)

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Who are Medifast's major shareholders?

Medifast's stock is owned by a number of retail and institutional investors. Top institutional investors include Chickasaw Capital Management LLC (0.28%), State of Alaska Department of Revenue (0.09%) and FNY Investment Advisers LLC (0.02%). Company insiders that own Medifast stock include Carl E Sassano, Constance J Hallquist, Daniel R Chard, Michael A Hoer and Scott Schlackman. View institutional ownership trends for Medifast.

Which major investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including Chickasaw Capital Management LLC. View insider buying and selling activity for Medifast.

Which major investors are buying Medifast stock?

MED stock was acquired by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, and State of Alaska Department of Revenue. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard, and Michael A Hoer. View insider buying and selling activity for Medifast.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $68.80.

How big of a company is Medifast?

Medifast has a market capitalization of $809.43 million and generates $713.67 million in revenue each year. The specialty retailer earns $77.92 million in net income (profit) each year or $5.96 on an earnings per share basis. Medifast employs 420 workers across the globe. View additional information about Medifast.

What is Medifast's official website?

The official website for Medifast is http://www.medifast1.com/.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel